Scientists have begun to uncover how the virus that causes most Merkel cell carcinoma — a rare and aggressive skin cancer — operates, meaning that a rational chemotherapeutic target for this cancer could be developed in the near future.
Scientists have begun to uncover how the virus that causes most Merkel cell carcinoma — a rare and aggressive skin cancer — operates, meaning that a rational chemotherapeutic target for this cancer could be developed in the near future.